Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.

导出 OA

翻译打印收藏纠错

第一作者： Severin,Vogt

第一单位： Division of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

作者： Severin,Vogt ^[1] ; Jörg D,Leuppi ^[2] ; Philipp,Schuetz ^[3] ; Beat,Mueller ^[4] ; Carmen,Volken ^[3] ; Sarah,Dräger ^[4] ; Marten,Trendelenburg ^[5] ; Jonas,Rutishauser ^[1] ; Michael,Osthoff ^[6]

作者单位： Division of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. ^[1] Department of Medicine, Kantonsspital Baselland, Liestal, Switzerland. ^[2] Medical University Department, Kantonsspital Aarau, Aarau, Switzerland. ^[3] Faculty of Medicine, University of Basel, Basel, Switzerland. ^[4] Central Laboratory, Kantonsspital Baselland, Bruderholz, Switzerland. ^[5] Department of Clinical Research, University of Basel, Basel, Switzerland. ^[6] Department of Medicine, Clinical Trial Unit, Kantonsspital Baden, Baden, Switzerland. ^[7] Division of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. Michael.Osthoff@usb.ch. ^[8] Department of Clinical Research, University of Basel, Basel, Switzerland. Michael.Osthoff@usb.ch. ^[9]

关键词 Chronic obstructive pulmonary disease Exacerbation Ficolin-2 Glucocorticoid treatment Immunoglobulin Mannose-binding lectin